Mar 15, 2023 4:19 pm EDT ResMed Announces Participation in the 2023 KeyBanc Life Sciences & MedTech Investor Forum
Mar 13, 2023 7:00 am EDT ResMed’s Annual Global Sleep Survey Finds 8 in 10 Adults Experience Signs of Disruption Related to Their Quality of Sleep
Mar 7, 2023 9:00 am EST ResMed Announces Participation in the Oppenheimer 33rd Annual Healthcare Conference
Jan 26, 2023 4:05 pm EST ResMed Appoints Michael Farrell as Chair of its Board of Directors Peter Farrell to Become Chair Emeritus
Jan 2, 2023 4:05 pm EST ResMed Announces Participation in the 41st Annual J.P. Morgan Healthcare Conference